Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -3.148% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] O=C(CN1CCN(Cc2ccccc2Cl)C1=O)N1CCCCCC1
[b] COc1cc(-c2cc(-c3ccccc3)nc(SCC(=O)Nc3nccs3)c2C#N)cc(OC)c1OC
[c] CCCOC(=O)C(C)n1cnc2sc(C)c(C)c2c1=O
[d] COc1cc(OC)cc(-c2nc(-c3ccc(Br)cc3)no2)c1
Answer: c. CCCOC(=O)C(C)n1cnc2sc(C)c(C)c2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOC(=O)C(C)n1cnc2sc(C)c(C)c2c1=O
CCCOC(=O)C(C)n1cnc2sc(C)c(C)c2c1=O
propyl 2-(5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-3-yl)propanoate